Firm will use the money to identify a subset of recombinant antigens that induce strong protection from candidate antigens found in the phase 1 STTR program.
Agreement covers development of compounds that modify three specific sodium ion channels as treatments for pain and related disorders.
Drug to treat constipation combines small molecule polymer conjugate technology platform with naloxol, a derivative of the opioid-antagonist, naloxone.
India-based CRO SIRO Clinpharm formed a strategic alliance with Cambridge Regulatory Services, a full-service regulatory consultancy for the pharmaceutical industry. The companies claim their...
Deal will exploit Ambrx’ biologics optimization technologies, ReCODE™ and EuCODE™. They enable site-selective substitution of novel amino acids.
India-based Hilleman Laboratories is considering developing vaccines that do not require refrigeration and a vaccine against Group A streptococci.
Deal pad GPCR and kinase research product lines as well as offerings for detection and screening of new drugs, radiolabeling, bead-based assays, HTS, and reagents.
CRO continues making inroads into Asia as well as Central and Eastern Europe. It previously acquired AbCRO and Magen, established an office in Tokyo.